Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery HER2

Path Created with Sketch.
Go to HER2 Normal Tissue GalleryGo back to Product Page
Immunohistochemistry with HER2 antibody clone MSVA-340R in Breast - Breast cancer of no special type (NST)- HER2- 1+
Breast- Breast cancer of no special type (NST)- HER2- 1+.
Breast- Breast cancer of no special type (NST)- HER2- 1+.
Breast- Breast cancer of no special type (NST)- HER2- 1+.
Breast- Breast cancer of no special type (NST)- HER2- 1+.
Immunohistochemistry with HER2 antibody clone MSVA-340R in Breast - Breast cancer of no special type (NST)- HER2- 2+
Breast- Breast cancer of no special type (NST)- HER2- 2+.
Breast- Breast cancer of no special type (NST)- HER2- 2+.
Breast- Breast cancer of no special type (NST)- HER2- 2+.
Breast- Breast cancer of no special type (NST)- HER2- 2+.
Breast- Breast cancer of no special type (NST)- HER2- 2+.
Breast- Breast cancer of no special type (NST)- HER2- 2+.
Immunohistochemistry with HER2 antibody clone MSVA-340R in Breast - Breast cancer of no special type (NST)- HER2- 3+
Breast- Breast cancer of no special type (NST)- HER2- 3+.
Breast- Breast cancer of no special type (NST)- HER2- 3+.
Breast- Breast cancer of no special type (NST)- HER2- 3+.
Breast- Breast cancer of no special type (NST)- HER2- 3+.
Breast- Breast cancer of no special type (NST)- HER2- 3+.
Breast- Breast cancer of no special type (NST)- HER2- 3+.
Immunohistochemistry with HER2 antibody clone MSVA-340R in Breast - HER2 negative invasive breast cancer of no special type (NST)
Breast- HER2 negative invasive breast cancer of no special type (NST).
Breast- HER2 negative invasive breast cancer of no special type (NST).
Breast- HER2 negative invasive breast cancer of no special type (NST).
Breast- HER2 negative invasive breast cancer of no special type (NST).
Immunohistochemistry with HER2 antibody clone MSVA-340R in Colon - HER2 negative colorectal adenocarcinoma
Colon- HER2 negative colorectal adenocarcinoma.
Colon- HER2 negative colorectal adenocarcinoma.
Immunohistochemistry with HER2 antibody clone MSVA-340R in Esophagus - HER2 negative adenocarcinoma
Esophagus- HER2 negative adenocarcinoma.
Esophagus- HER2 negative adenocarcinoma.
Esophagus- HER2 negative squamous cell carcinoma.
Esophagus- HER2 negative squamous cell carcinoma.
Kidney- HER2 negative clear cell renal cell carcinoma.
Kidney- HER2 negative clear cell renal cell carcinoma.
Kidney- HER2 negative papillary renal cell carcinoma.
Kidney- HER2 negative papillary renal cell carcinoma.
Prostate- HER2 negative adenocarcinoma (Gleason 3+3=6).
Prostate- HER2 negative adenocarcinoma (Gleason 3+3=6).
Stomach- Gastric adenocarcinoma (HER2- 2+)
Stomach- Gastric adenocarcinoma (HER2- 2+)
Stomach- Gastric adenocarcinoma (HER2- 2+).
Stomach- Gastric adenocarcinoma (HER2- 2+).
Stomach- HER2 negative gastric adenocarcinoma.
Stomach- HER2 negative gastric adenocarcinoma.
Stomach- HER2 negative gastric adenocarcinoma.
Stomach- HER2 negative gastric adenocarcinoma.
Stomach- HER2 positive gastric adenocarcinoma (HER2- 3+).
Stomach- HER2 positive gastric adenocarcinoma (HER2- 3+).
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors